Page 4 - Briefing Documents News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Out. intel quickly realized he wasn't going to read briefing documents and had to bring charts and pictures. what did the former president do? >> reporter: they had taken to bringing in images and catchy graphics and charts. i was told as soon as he saw this image he said, i'm tweeting it. the intelligence officials in the room were trying to talk him out of it, saying, sir, we spent billions of dollars on this satellite system. if you put this out, you're going to show the adversaries our capabilities. he just didn't care. he said i'm president, i can declassify anything, right? they said yes...

But again, i've not seen the data yet, so i'm going to suspend my opinion until i see those briefing documents. >> i wonder if you just gave me an answer to this, but do we know if immunocompromised children are part of this trial, this study, and what would be the message you give parents with those specific concerns? >> right. so, i have not yet seen the study documents to know its design. certainly, you know, we begin with assessing safety. vaccines you give to healthy people so they better be safe so there will be very close scrutiny of the safety data for this vaccine and any age group, a...

Deliberate in public session all day, tuesday, and at the end, if our meeting -- whether the evidence of supports benefit over risk of the pfizer mrna vaccine for children 5 to 11 years of age. that briefing documents have been posted publicly on the fda website. any american can download them and look at them. there's always the same two considerations, safety and efficacy. vaccines we give to healthy people so they can better be safe. i don't want to preach on their deliberations. let's let the process play out. we'll hear from the sponsor, pfizer, presenting the results. they will summarize...

Briefing documents for moderna and pfizer, with one dose they reached about 35 to 45%. it was the second dose that got them to 94 or 95%. so it's the same two-dose regiment as moderna and pfizer. >> even though one dose is appealing to a lot of people, even though the efficacy rate is a little low, it does inspire more people who actually get vaccinated? >> no, absolutely. we certainly have groups that absolutely benefit from this johnson & johnson vaccine. and we want to have always remember that. and also, we want to know that it was 100% protected against death and hospitalization. those we...

Available for the third pfizer shot. day two continues to consider boosters from johnson & johnson and mix and matching vaccine doses. questions have been raised about the data presented by both manufacturers here. briefing documents made available prior to the meeting show the fda's mixed opinion on whether extra shots is necessary and whether the data is sufficient. johnson & johnson recipients may be better off getting a pfizer or moderna booster. there's a lot to get into. we have monica alba and dr. peter otez. he directs the center for vaccine development at texas children's hospital and...